EGFR and cancer: There are 764 'cancer or benign tumor'diseases or phenotypes associated with EGFR, predicted by the 'Open Targets Platform' [8].The Open Targets Platform is a powerful resource that facilitates the methodical discovery and ranking of promising targets fortherapeutic drugs.